Abstract
SCS is proven to be an effective remedy to control neuropathic pain in adults. However, SCS is not confirmed as safe and efficient in treating younger patients, particularly longer-term. For these reasons SCS uses among youth have been limited. Pediatrics patients are less susceptible to chronic pain from nerve injuries probably due to the relative immaturity of the nervous system and neuroimmune profile pre and post-adolescence. The etiology of neuropathic pain is rare in children and it varies between adults and children, which are unusually diagnosed with trigeminal or postherpetic neuralgia and painful diabetic neuropathy [1,2,3].
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Neuromodulation: Technology at the Neural Interface
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
